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Purpose: In the Icelandic and Swedish populations, pseudoexfoliation syndrome (XFS) and pseudoexfoliation glaucoma
(XFG) has been significantly associated with LOXL1 exon 1 polymorphisms - allele G of rs1048661 (R141L) and allele
G of rs3825942 (G135D). In this study, we looked at the association of rs1048661 and rs3825942 in a southern Indian
population.
Methods: Fifty-two cases with XFS (including XFG) and 97 matched controls that had thorough glaucoma evaluations
were included in the study. Exon 1 of the LOXL1 gene with the single nucleotide polymorphisms (SNPs) were amplified
and sequenced. For statistical significance, Pearson’s Χ2 test was performed. The HAPLOVIEW program v4.0 was used
to determine the Hardy–Weinberg equilibrium and haplotype association.
Results: In our study population, there was a significant association of allele G of rs3825942 with XFS (p=0.0001) and
genotype GG (p=0.000305) with XFS.
Conclusions: Out of the two non-synonymous SNPs in exon 1 of the LOXL1 gene, rs3825942 has a significant association
with XFS cases in the patients of the southern Indian population. To the best of our knowledge, this is the first Asian study
replicating the European studies.
Pseudoexfoliation syndrome (XFS) is an age-related,
systemic, elastic microfibrillopathy affecting both intraocular
and extraocular tissues [1]. In the eye, XFS is characterized
by the presence of fibrogranular extracellular debris in the
anterior segment, which is composed of a complex
glycoprotein–proteoglycan structure having epitopes of a
basement membrane, elastic fiber system, and components of
elastic microfibrils [2]. The average worldwide prevalence of
XFS is 10%–20% of the general population over the age of 60
years. However, studies have shown much higher prevalence
in certain populations like Scandinavian countries and Greece
[3-5].
Glaucoma, the second most common cause of blindness,
is a heterogeneous group of disorders characterized by optic
nerve damage [6]. XFS is the most common identifiable cause
of secondary glaucoma such as pseudoexfoliation glaucoma
(XFG), which is due to the accumulation of the exfoliative
material [7]. The risk of XFS converting to XFG over a period
of 15 years is about 60% [8,9].
Linkage studies on a large Finnish family showing an
autosomal dominant mode of inheritance for XFS trait
identified a locus, 18q12.1–21.33, with a two point LOD score
of 3.45 and a multipoint LOD score of 4.2 and few other loci
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like 2q, 17p, and 19q previously linked to primary open angle
glaucoma [2]. Familial aggregation and the increased
frequency of XFS and glaucoma in relatives of affected
subjects compared with relatives of unaffected subjects
clearly suggests an underlying genetic component [10,11].
A recent genome wide association study on Icelandic
patients identified three single nucleotide polymorphisms
(SNPs) on chromosome 15q24.1 to be significantly associated
with XFS and XFG.
The three SNPs are, allele T of rs2165241 in the first
intron and allele G of rs1048661 (R141L) and allele G of
rs3825942 (G135D) in exon 1 LOXL1. The association was
further confirmed in a Swedish population, and the combined
p values of the SNPs were 1.0x10-27 (rs2165241), 2.3x10-12
(rs1048661) and 3.0x10-21 (rs3825942) [9]. LOXL1 gene
expression is detected in ocular tissues, and it is a member of
the lysyl oxidase family of proteins [12]. This protein is
involved in catalyzing the deamination of lysine residues of
tropoelastin, causing cross-linking and the formation of
elastin polymer fibers [13,14]. The pathological process of
XFS is characterized by chronic accumulation of abnormal
fibrillar material in the anterior segment of the eye, leading to
numerous clinical complications apart from secondary
glaucoma [7]. Though the precise role of LOXL1 in the XFS
is not known, it could possibly contribute to the pathogenesis
due to the accumulation of abnormal elastin microfibrillar
components.
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318In this study, we have genotyped the two non-
synonymous SNPs, rs1048661 and rs3825942, in the XFS and
compared it with normal controls in a southern Indian
population.
METHODS
Cases and controls: Fifty-two cases of XFS with or without
glaucoma or ocular hypertension and 97 matched healthy
controls were taken for the study. Cases and controls were
matched for age, gender, and ethnicity. Subjects and controls
were recruited from the glaucoma clinic at the hospital and
also from a population-based survey that was being conducted
at the Sankara Nethralaya Eye Hospital in Chennai, India after
the approval of the local research ethics committee. All
subjects and controls underwent a comprehensive ocular
examination including vision and refraction, slit lamp
assessment, applanation tonometry, gonioscopy, and dilated
stereobiomicroscopic optic disc and retinal examination.
Presence of pseudoexfoliation was diagnosed if the
pseudoexfoliative material was detected on the pupillary ruff
or anterior lens capsule.
Only bilaterally phakic subjects were enrolled as
controls. Blood samples were collected from the cases and
controls after obtaining an informed consent, and the study
procedures were performed in accordance with Institutional
Review Board guidelines and the Declaration of Helsinki.
Polymerase chain reaction and sequencing: The region of the
LOXL1 gene harboring the SNPs, rs1048661 (R141L) G and
rs3825942 (G153D) G, was amplified and sequenced to
genotype the SNPs. The fragment containing the SNPs were
amplified using the primers, 5′ ATT CGG CTT TGG CCA
GGT 3′ and 5′ GAA CTG CTG CGG GTA GGA 3′, in a 20
μl reaction containing 10 mM Tris (pH 9.0), 50 mM KCl, 1.5
mM MgCl2 and 0.01% gelatin, 1 mM dNTP each (GeNei,
Bangalore, India), 10 μM of each forward and reverse primer,
1 U of Taq DNA polymerase (GeNei, Bangalore, India), 5 mM
betaine (Sigma Aldrich, St. Louis, MO), and 100 ng of
genomic DNA.
The polymerase chain reaction (PCR) protocol was as
follows: initial denaturation at 94 °C for 5 min followed by
denaturation at 94 °C for 30 s, annealing at 58–55 °C
touchdown for 30 s with 0.5 °C decrement for the first six
cycles, extension at 72 °C for 45 s for 35 cycles, and a final
extension of 72 °C for 5 min. PCR products were digested
with exonuclease I and E.coli and shrimp alkaline phosphatase
(Fermentas, Life Sciences, Glen Burnie, MD). The purified
PCR products were sequenced unidirectionally using BigDye
Terminator v.3.1 kit (Applied Biosystems, Foster City, CA)
with specific primers in ABI3100 Avant (Applied
Biosystems). The sequences were analyzed in Sequence
Analysis software v.3.1.1.
Statistical analysis: Statistical analysis was performed using
SPSS# version 14.0. Those with pseudoexfoliation
(irrespective of the presence or absence of glaucoma or ocular
hypertension) were compared to the control population.
Pearson’s Χ2 test (adjusted by Yates correction where
necessary) was used to compare patient and control groups for
possible associations between SNP allele frequency/
haplotype frequency and disease state. Bonferroni correction
for multiple tests was applied and a p value of less than
0.00625 was considered significant. Odds ratios were also
calculated. Linkage disequilibrium analysis and checking of
conformance of Hardy–Weinberg equilibrium were done
using the HAPLOVIEW program (version 4.0). It calculates
several pair-wise measures of linkage disequilibrium (LD).
Individual haplotypes and their estimated population
frequencies were inferred using the HAPLOVIEW program
with all parameters set at the default values. The genotype data
were loaded as unphased diplotypes in a standard linkage
format. Marker information including the name and physical
location was loaded separately.
RESULTS
A total of 52 cases (22 XFS, 11 XFS + ocular hypertension
[OHT], and 19 XFG) and 97 unrelated controls all of south
Indian ethnicity were studied. Cases ranged in age from 45 to
107 with an average age of 68.9 (standard deviation: 11.43)
years. The controls were in the age range of 46 to 84 with an
average age of 64.1 (SD: 7.2) years. Among the cases, there
were 27 males and 25 females, and among the controls, there
were 52 males and 45 females. Summary of the clinical
features of patients is given in Table 1.
Between the two non-synonymous SNPs, rs1048661 did
not show an association with XFS (p=0.156 for allele G, odds
ratio (OR)=1.49, confidence interval (CI) – 0.89 −2.51),
whereas allele G of rs3825942 showed a significant
association (p=0.0001, OR=4.17, CI – 1.89–9.18). Case-
control ratios of associated allele G of rs1048661 and
TABLE 1. CLINICAL CHARACTERISTICS OF SUBJECTS WITH PSEUDOEXFOLIATION SYNDROME.
Intraocular pressure mean (SD) VCDR* Median (SD)
Pseudoexfoliation with glaucoma 23.4 (9.79) 0.81 (0.13)
Psedoexfoliation with ocular hypertension 24.1 (5.17) 0.6 (0.16)
Pseudoexfoliation 14.3 (2.62) 0.5 (0.27)
The asterisk indicates the vertical cup to disc ratio. In bilateral cases, the eye with greater optic disc damage (XFG) or IOP
(ocular hypertension or XFS) has been included. None of the patients were on medication at presentation.
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319rs3825942 are shown in Table 2. Genotype GG of the
rs1048661 was also not significantly associated with XFS
(p=0.058), and similar to the allelic association, genotype GG
of rs3825942 was significantly associated with XFS
(p=0.000305; Table 2).
Allelic frequencies of both the SNPs in cases and controls
were in Hardy–Weinberg equilibrium. The observed (0.473)
and expected (0.443) heterozygosity for rs1048661 did not
differ significantly (p=0.55). Similarly, there was no
departure in the observed (0.311) and expected (0.315)
heterozygosity for rs3825942 (p=1).
The two SNPs are in linkage disequilibrium (D’=1), and
as observed in the Icelandic study, only three of the four
possible haplotypes were detected in our samples.
Further comparing the haplotype results, the (G, G) had
an OR of 5.73 (p<0.0001, CI – 2.534, 12.98) and the (T, G)
had an OR of 2.55 (CI – 1.08, 6.05, p=0.0476) relative to (G,
A). Relative to (T, G), the (G, G) had an OR of 2.22 (p=0.0006,
CI −1.28, 3.82) and (G, A) had an OR of 0.21 (p=0.0002, CI
−0.093, 0.49). Among the three observed haplotypes, (G, A)
has a protective effect.
We did not find any other polymorphisms either in the
cases or controls except for the SNPs mentioned earlier in
exon 1 of the gene.
DISCUSSION
XFS is an age-related, systemic, elastic microfibrillopathy
characterized by the production of abnormal basement
membrane-like material in several intraocular and extraocular
tissues. It is the most common cause of secondary open angle
glaucoma worldwide [1].
Genetic and environmental factors have been implicated
in the pathogenesis of XFS. In a recent breakthrough genome-
wide association study done in an Icelandic population, which
was replicated in a Swedish population, the genetic etiology
of XFS and its associated glaucoma was unraveled.
Polymorphisms in the coding region of the LOXL1 gene
located on chromosome 15q24.1 are strongly associated with
XFS and XFG in these populations [9]. The Thorleifsson et
al. [9] study have shown a strong association of XFS and XFG
with two known non-synonymous SNPs, rs1048661
(Arg→Leu, R141L) and rs3825942 (Gly→Leu, G135D), of
the LOXL1 gene.
In the present study, we have identified 52 cases (22 XFS,
11 XFS+OHT, and 19 XFG) and 97 unrelated controls of
south Indian ethnicity. In the identified cases and controls, we
genotyped the two non-synonymous SNPs, rs1048661
(Arg→Leu, R141L) and rs3825942 (Gly→Leu, G135D),
which are located in exon 1 of the LOXL1 gene.
When compared to the Icelandic study, we did not find
significant association with rs1048661, but we replicated the
significant association of allele G of SNP, rs3825942
(p=0.0001, OR=4.17, CI – 1.89–9.18). It is interesting that
Thorleifsson et al. [9] demonstrated that the expression of
LOXL1 was reduced by an estimated 7.7% with each copy
carrying the risk G allele of rs1048661. The lack of association
seen for the G allele of rs1048661 in the present study may be
attributed to the fact that the sample size was small. Similar
to the Icelandic study, only three of the four possible
haplotypes were detected in our samples. Among the three
observed haplotypes, (G,G) was strongly associated with XFS
(OR of 3.001, CI – 1.83, 4.91, p=9.9   10 −6). (G,A) has a
significant protective effect (p=2.0   10 −4) as it is seen more
in controls (Table 3).
The LOXL1 gene is a member of the lysyl oxidase gene
family. The prototypic member of the family is essential for
the biogenesis of connective tissue and encodes for an
extracellular copper-dependent amine oxidase that catalyzes
the first step in the formation of cross-links in collagens and
elastin [15]. Lysyl oxidases (LOX) and lysyl oxidase-like-
TABLE 2. LOXL1 ALLELE/GENOTYPE COUNT AND FREQUENCIES IN CASES AND CONTROLS.
SNP Cases Controls p value






R141L (rs1048661) G 75 0.72 123 0.63 0.156
T 29 0.27 71 0.36
G153D (rs3825942) G 96 0.92 144 0.74 0.0001
A 8 0.07 50 0.25
R141L (rs1048661) GG 29 0.55 36 0.37 0.058
GT 17 0.32 51 0.52
TT 6 0.11 10 0.1
G153D (rs3825942) GG 45 0.86 52 0.53 0.000305
GA 6 0.11 40 0.41
AA 1 0.01 5 0.05
Allelic/genotype association testing results of rs1048661 (R141L) and rs3825942 (G135D) SNPs in exon 1 of LOXL1 with
pseudoexfoliation syndrome (XFS) in Indian cases and controls.
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320proteins form an enzyme family with diverse NH2-termini and
conserved COOH-terminal lysyl oxidase (LOX) domains. A
highly conserved amino acid sequence at the COOH-terminus
end appears to be sufficient for amine-oxidase activity,
indicating that each member of the protein family may have
this particular function [16].
In addition to LOX and LOXL1, three closely related
LOX-like proteins were identified in mammals in the past
decade, LOXL2, LOXL3, and LOXL4 [16]. Although the
LOX family members share some homology, each of the
genes are located on different chromosomes; LOX is located
on chromosome 5q23.1, LOXL1 on chromosome 15q24.1,
LOXL2 on chromosome 8p21.3, LOXL3 on chromosome
2p13.1, and LOXL4 on chromosome 10q24.2 as per the human
genome data at Ensembl.
In the case of age-related macular degeneration (AMD),
the identification and validation of the association between
the CFH gene variants and AMD [17] made many
investigators look at other genes in the complement factor H
related family (CFHR) genes like complement factor B (BF)
and complement component 2 (C2) [18]. Further work
revealed the strong association of CFHR genes with AMD.
Similarly, it would be worth hypothesizing that other LOX
family member genes (LOX, LOXL2, LOXL3, and LOXL4)
could be strong candidates whose variants might be associated
with XFS and/or XFG. The prevalence of pseudoexfoliation
syndrome in India has been reported to be between 3% and
6% in those aged 40 years and above [19-21]. XFS is strongly
associated with not only cataract and complications of cataract
surgery but also open angle glaucoma, and it shows an
increasing prevalence with age [22]. Pseudoexfoliation was
associated with a significantly greater risk of blindness
secondary to these causes. Hence, this finding gains
importance and has public health implications for India.
In summary, our results showed that of the two non-
synonymous SNPs in exon 1 of the LOXL1 gene that were
shown to be significantly associated with XFS, rs3825942
(G135D) conferred a significant risk to develop the disease in
the Indian population. To the best of our knowledge, this is
the first study showing an association of LOXL1 gene
polymorphism and XFS in the Asian population.
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